β¨ Medicines Distribution Consent
14 NOVEMBER 2013 NEW ZEALAND GAZETTE, No. 150 4149
Product: Arrow - Aripiprazole
Active Ingredient: Aripiprazole 30mg
Dosage Form: Tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturer: Unichem Laboratories Limited, Ghaziabad, India
Product: Benztrop
Active Ingredient: Benzatropine mesilate 2mg
Dosage Form: Tablet
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Pharmascience Inc, Quebec, Canada
Product: Capecitabine Winthrop
Active Ingredient: Capecitabine 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Remedica Limited, Limassol, Cyprus
Product: Capecitabine Winthrop
Active Ingredient: Capecitabine 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: sanofi-aventis new zealand limited
Manufacturer: Remedica Limited, Limassol, Cyprus
Product: NicoQuit (Mint)
Active Ingredient: Nicotine polacrilex 14.9mg equivalent to Nicotine 2mg
Dosage Form: Chewing gum
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Fertin Pharma A/S, Vejle, Denmark
Product: NicoQuit (Mint)
Active Ingredient: Nicotine polacrilex 29.9mg equivalent to Nicotine 4mg
Dosage Form: Chewing gum
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Fertin Pharma A/S, Vejle, Denmark
Product: NicoQuit (Fruit)
Active Ingredient: Nicotine polacrilex 14.9mg equivalent to Nicotine 2mg
Dosage Form: Chewing gum
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Fertin Pharma A/S, Vejle, Denmark
Product: NicoQuit (Fruit)
Active Ingredient: Nicotine polacrilex 29.9mg equivalent to Nicotine 4mg
Dosage Form: Chewing gum
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Fertin Pharma A/S, Vejle Denmark
Dated this 7th day of November 2013.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go7235
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Galvus
Active Ingredient: Vildagliptin 50mg
Dosage Form: Tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Farmaceutica SA, Barcelona, Spain
Novartis Pharma Stein AG, Stein, Switzerland
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare7 November 2013
Medicines, Consent, Distribution, Arrow - Aripiprazole, Benztrop, Capecitabine Winthrop, NicoQuit, Galvus
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
NZ Gazette 2013, No 150